Company filings profile · CIK 0001659617

Moleculin Biotech, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Moleculin Biotech, Inc. (MBRX): 25 filings in the last 90 days vs 18 in the prior 90 (filing-velocity rising ↑ · 1.39×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.

Material 8-K events — Moleculin Biotech, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Aug 3, 2026Entry into a Material Agreement; Financial Statements and Exhibits
Jul 31, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 5, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 29, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 26, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 22, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 15, 2026Results of Operations (earnings); Financial Statements and Exhibits
May 13, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 12, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 8, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Apr 23, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Apr 15, 2026Item 5.07
Mar 23, 2026Regulation FD Disclosure; Financial Statements and Exhibits

Watch Moleculin Biotech, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Aug 5, 20264
Aug 5, 20264
Aug 5, 20264
Jun 24, 20264
Jun 24, 20264
Jun 24, 20264

Recent filings

FiledFormDetail
Aug 5, 20264 FORM 4
Aug 5, 20264 FORM 4
Aug 5, 20264 FORM 4
Aug 3, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits
Aug 3, 2026424B5 FORM 424B5
Jul 31, 2026EFFECT Item ; Item ; Item
Jul 31, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jul 31, 2026S-1/A FORM S-1/A
Jul 30, 2026S-1/A FORM S-1/A
Jul 29, 2026S-1 FORM S-1
Jul 15, 2026DRS
Jun 30, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 30, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 24, 20264 FORM 4
Jun 24, 20264 FORM 4
Jun 24, 20264 FORM 4
Jun 5, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 29, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 26, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 22, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 15, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
May 14, 202610-Q FORM 10-Q
May 13, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 12, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 8, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Apr 23, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Apr 15, 20268-K Item 5.07
Apr 14, 2026EFFECT Item ; Item ; Item
Apr 14, 202610-K/A FORM 10-K/A
Apr 14, 2026424B3 FORM 424B3
Apr 10, 2026CORRESP
Apr 2, 2026UPLOAD
Mar 27, 2026S-3 FORM S-3
Mar 23, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Mar 19, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Mar 19, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Mar 18, 202610-K FORM 10-K
Mar 9, 2026DEF 14A FORM DEF 14A
Feb 26, 2026PRE 14A FORM PRE 14A
Feb 20, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits